Plus Therapeutics to trade on Nasdaq as Cerenome under CNSY ticker from Aug. 3
Cerenome Launches as an Integrated CNS Oncology Company | PSTV Stock News
Plus Therapeutics signs Medical Mutual coverage deal for CNSide CSF tumor cell assay in Ohio, Kentucky
A New CNS Cancer Treatment Playbook In The Making?
Plus Therapeutics partners with Genomic Testing Cooperative to add NGS to CNSide CSF assay platform
From Buybacks to Insider Buying: U.S. Mid-Caps Signal Capital Shift